日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Underpowered trials at trial start and informed consent: action is needed beyond the COVID-19 pandemic

试验开始时样本量不足以及知情同意问题:需要采取行动,而这需要超越新冠疫情的影响。

Dal-Ré, Rafael; Eriksson, Stefan; Latham, Stephen R

How WHO Solidarity Plus trial participants in countries on four continents are informed in writing

世界卫生组织“团结+”试验参与者在四大洲各国如何以书面形式获知相关信息

Dal-Ré, Rafael; Voo, Teck Chuan; Holm, Søren

Adaptive, platform trials assessing therapies for hospitalized COVID-19 patients: Informed consent forms omitted a few important elements of information

针对住院新冠肺炎患者治疗方案的适应性平台试验:知情同意书遗漏了一些重要的信息要素

Dal-Ré, Rafael; Voo, Teck Chuan; Holm, Søren

Vaccine certificates for international travelers in future pandemics

未来疫情期间国际旅行者的疫苗接种证明

Dal-Ré, Rafael; Becker, Sören L; Launay, Odile; Pavli, Androula

Waivers of informed consent in research with competent participants and the Declaration of Helsinki

在有行为能力参与者的研究中豁免知情同意与《赫尔辛基宣言》

Dal-Ré, Rafael

Off-label prescription of BNT162b2 mRNA COVID-19 vaccine to <5-year-old children in the European Union

欧盟允许对5岁以下儿童超适应症使用BNT162b2 mRNA新冠疫苗

Dal-Ré, Rafael; Calvo, Cristina; Neth, Olaf

The approach to informed consent in acute care research

急性护理研究中知情同意的方法

Dal-Ré, Rafael; Caplan, Arthur L

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

口服抗病毒药物在治疗SARS-CoV-2感染中的应用及其伦理处方原则的重要性

Dal-Ré, Rafael; Becker, Sören L; Bottieau, Emmanuel; Holm, Søren

COVID-19 drug research and the cohort multiple randomised controlled trial design

COVID-19 药物研究和队列多重随机对照试验设计

Dal-Ré, Rafael

Single research ethics committee review for multinational trials is a misconception

由单一研究伦理委员会对跨国试验进行审查是一种误解。

Dal-Ré, Rafael